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Infection of cells of the central nervous system by the
human immunodeficiency virus type-1 (HIV-1) leads to
HIV-1-associated neuropathology. Recent studies have
demonstrated the importance of long terminal repeat
(LTR) binding sites in determining the pathogenicity of
HIV. Here we have investigated the presence and the
functional role of transcription factors that have the
potential to interact, directly or indirectly, with the nu-
clear receptor-responsive element in the LTR of HIV-1,
in different human cell lines of the brain. Cotransfection
experiments showed that in oligodendroglioma TC-620
cells, the retinoic acid receptor and the retinoid X re-
ceptor activate LTR-driven transcription in the absence
of ligand. Addition of all-trans- or 9-cis-retinoic acid re-
verses this effect. In contrast, in astrocytoma, neuronal,
and microglial cells, no significant effect of the retinoid
acid pathway was detected. This retinoid response is
mediated by distinct molecular interactions in the lym-
photropic LAI and the neurotropic JR-CSF HIV-1
strains. Moreover, retinoid receptors were found to an-
tagonize the chicken ovalbumin upstream promoter
transcription factor- as well as the c-JUN-mediated LTR
transactivation. Our findings demonstrate the impor-
tance of the retinoic acid signaling pathway and of
cross-coupling interactions in the repression of HIV-1
LTR gene expression.
The molecular mechanisms controlling HIV-11 pathogenesis
in the central nervous system are not understood. Tissue
macrophages and microglial cells are major target cells and
reservoirs for virus during HIV disease in the brain. In addi-
tion, infection of neuronal and glial cells also appears to con-
tribute to HIV-1-related pathology (1–4). HIV-1 gene expres-
sion is regulated by an interplay of viral and cellular host
proteins that interact with a number of binding sites present in
the long terminal repeat (LTR) (5). Recent reports highlighted
the importance of the U3 region of the LTR in determining the
pathogenicity of HIV-1 (6). Therefore studies concerning the
various elements of the modulatory region of the LTR and their
interaction with host proteins present in brain cells appear
quite crucial.
Transcription factors belonging to the steroid-thyroid-retin-
oid nuclear receptor superfamily have been shown to interact
with the nuclear receptor-responsive element (NRRE) located
within the 2356/2320 region of the LTR (7–10). The NRRE
sequence represents a site for complex regulatory interactions
among a variety of hormone receptors, orphan receptors as well
as the AP-1 transcription factor. We have recently reported
that AP-1 is unable to bind directly to the NRRE sequence and
that it interacts with the 2247/2222 sequence present in neu-
rotropic HIV-1 strains (10); however, indirect binding of a FOS
protein to the NRRE site has been reported (11). Our recent
findings indicate that COUP-TF (chicken ovalbumin upstream
promoter transcription factor), an orphan member of the hor-
mone receptor superfamily (12, 13), is one of the major species
that binds to the NRRE and functions as a potent activator of
LTR-driven transcription in brain cells.2 A number of studies
have described that retinoic acid receptors (RARs) and retinoid
X receptors (RXRs), in the presence of their ligand, modulate
LTR-driven transcription in non-CNS-derived cells. 9-cis-Reti-
noic acid (RA) activates both RARs and RXRs, whereas all-
trans-RA only activates RARs (14). Ligand-dependent stimula-
tion of LTR-directed transcription by RARa and RXRa was
observed in choriocarcinoma JEG-3 cells (9) and in CV1 cells,
via the NRRE site (8). In the presence of phorbol myristate
acetate, transcriptional activity was enhanced in U937 mono-
cytes treated with RA, through a distinct RA and phorbol
myristate acetate-responsive element located in the 283/180
LTR region (15). A negative effect of RA on HIV LTR activity
was documented in HeLa and U937 cells, via the NF-kB ele-
ment (16). Moreover, various effects of RA on the replication of
HIV in different cell types have been reported (17–19). Taken
together, these data reveal the importance of the type of target
cell in the RAR- and RXR-mediated transcriptional response
and point out that distinct molecular mechanisms control the
retinoid signaling pathway.
In this report we have investigated the presence of members
of the RAR and RXR family in various cell types of the brain.
We have further examined the functional effect of RAR-a,
RXR-a, and RA treatment on HIV-1 LTR-driven transcription
in human neuronal, glial, and microglial cells. Our results
show that the nuclear receptors regulate HIV-1 gene expres-
sion in a unique manner; unliganded RAR and RXR lead to
activation, whereas the addition of RA antagonizes the recep-
tor-mediated activation in oligodendroglioma cells. Moreover,
we elucidate the interactive physiological networks of the ret-
inoid receptors RAR and RXR, of the orphan receptor
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COUP-TF and the transcription factor AP-1, in the regulation
of HIV-1 gene expression in various cells of the brain. We show
that the retinoid receptors function as repressors of COUP-TF-
mediated transactivation and that RXR acts as a repressor of
c-JUN-mediated transactivation. Our findings reveal the im-
portance of retinoic acid as well as of cross-coupling interac-
tions in the inhibition of LTR-driven HIV-1 gene transcription.
MATERIALS AND METHODS
Plasmids—To generate LTR(JR-CSF)-CAT, 2283/120LTR-CAT,
2159/120 LTR-CAT, the plasmid pSAFYre containing the JR-CSF LTR
(gift of Dr. J. Clements; Ref. 20) was digested with EcoRV 1 BglII,
EarI 1 BglII, and AvaI 1 BglII, respectively. The LTR inserts were
isolated, blunt-ended, and subcloned in the SmaI site of pUC19-CAT0.
To generate LTR(LAI)-CAT, 2283/180LTR-CAT and 2159/180LTR-
CAT, the plasmid pSV1b-CAT containing the LAI LTR (gift of Dr. N.
Israel) was digested with BglII 1 HindIII, EarI 1 HindIII, and
AvaI 1 HindIII, respectively. The LTR inserts were blunt-ended and
subcloned in the SmaI site of pUC19-CAT0. The 268/129 LTR-CAT
vector was constructed by subcloning in the SmaI site of pUC19-CAT0
the BstNI-BstNI blunt-ended LTR insert. To construct the LTRmut3-
CAT vectors, site-directed mutagenesis was performed with the mutant
oligonucleotide 3Lmut: 59-CCAGGGGTAAGATATCCACAAAGCTTTG-
39. To construct the 3L/tk-CAT and 3Lmut/tk-CAT vectors, one copy of
the 3L and 3Lmut oligonucleotide was respectively subcloned in the
blunt-ended SalI site of pBLCAT2, containing the herpes simplex virus
thymidine kinase promoter in front of the CAT gene (gift of C. Kedinger,
Unite´ INSERM 184, Strasbourg, France). The human RAR-a and
RXR-a cDNA in the pSG1 vector and the reporter vector containing the
RARE DR5G sequence inserted in pBLCAT81 were a gift of P. Cham-
bon (21). The hc-JUN vector was a gift from C. Quirin-Stricker (Unite´
INSERM 184, Strasbourg, France), and the COUP-TF vector was a gift
from M. J. Tsai (Baylor College of Medicine, Houston, TX).
Cell Culture—Human astrocytoma U373-MG (ATCC HTB17), neu-
roblastoma SK-N-MC cells (ATCC HTB10), and microglial cells (gift of
M. Tardieu; Ref. 22) were grown in Dulbecco’s modified Eagle’s medium
supplemented with 10% charcoal-stripped fetal calf serum and 10 mM
HEPES. The medium of neuroblastoma SK-N-MC cells was supple-
mented with nonessential amino acids. All these cell lines were cultured
in the presence of penicillin/streptomycin (100 units/ml). Human oligo-
dendroglioma TC-620 cells (gift of J. E. Merrill; Ref. 23) were grown in
Iscove medium, containing 10% nonheat-inactivated fetal calf serum
and 1% gentamycin.
Transfections and CAT Assays—Cells (106) cultured in medium con-
taining 10% charcoal-stripped fetal calf serum were transfected by the
calcium phosphate precipitation method with 1 pmol of plasmid re-
porter DNA and when indicated with 0.5 pmol of expression vector, as
described previously (24). 24 h after transfection, cells were treated for
24 h with 1 mM all-trans-RA or 9-cis-RA in ethanol or with 0.1% ethanol
final concentration as a control. Each transfection was done in duplicate
and repeated a minimum of three separate times with at least two
different plasmid preparations. Cell extracts were prepared 48 h after
transfection. CAT assays were performed as described previously (24).
Since the efficiency of transfection is different in the different cell lines,
different amounts of cell extracts were used, 5, 5, 10, and 20 mg of
protein for microglial, astrocytoma, oligodendroglioma, and neuroblas-
toma cells, respectively.
Western Blot Analysis—Nuclear proteins were extracted from at
least 108 cells, as described previously (25). Proteins (10 mg) were
subjected to SDS-polyacrylamide gel electrophoresis (10% polyacryl-
amide) and transferred to nitrocellulose paper. Membranes were pre-
incubated with 3% bovine serum albumin in phosphate-buffered saline
(PBS) overnight at 4 °C and were probed either with polyclonal anti-
bodies directed against RAR-a (RPaF), RAR-b (RPbF2), RAR-g (RPgF),
or with monoclonal antibodies directed against RAR-a (AB9aF), RAR-b
(Ab8bF2), RAR-g (Ab4gF), RXR-a, -b, -g (1RX-6G12) (1:2000 dilution;
gift of P. Chambon) for 90 min at room temperature in PBS-0.1% Tween
20 (PBST). After three washes with PBST, membranes were incubated
with peroxidase-labeled anti-rabbit antibody (1:4,000 dilution; Amer-
sham Corp.) for 40 min and washed four times for 30 min in PBST. The
signal was visualized by the chemiluminescence protocol (Amersham
Corp.).
RESULTS
Pattern of RAR and RXR Expression in Different Human
Brain Cells—To analyze the functional effect of retinoid control
of HIV in different human brain cells, we first examined the
presence of endogenous retinoic acid receptors RAR-a, -b, or -g
and RXR-a, -b, or -g. Western blot analysis was performed with
nuclear protein extracts from human oligodendroglioma TC-
620, astrocytoma U373-MG, neuroblastoma SK-N-MC, and mi-
croglial cells using a set of monoclonal antibodies directed
specifically against human RAR-a, RAR-b, RAR-g, and RXR-a,
-b, -g (26, 27). As shown in Fig. 1, the expected RAR-a species
with an apparent molecular mass of 51 kilodalton (kDa) were
detected with antibodies Ab9aF; RAR-a was expressed at a
high level in SK-N-MC and TC-620 cells. With microglial pro-
teins, a 40-kDa band, specifically detected with antibodies
Ab9aF, could correspond to a truncated RAR-a resulting either
from alternative splicing events or artifactual proteolysis.
RAR-b of expected molecular mass 51 kDa was recognized with
antibodies Ab8b(F)2, only with SK-N-MC and TC-620 proteins.
Antibodies Ab4gF allowed the detection, only in glial cells, of
RAR-g of expected molecular mass 51 kDa. Antibodies
1RX6G12 specific for RXR-a, -b, and -g detected RXR species in
glial and neuronal cells but not in microglial cells. Similar
results were obtained when the blots were probed with poly-
clonal antibodies, instead of monoclonal antibodies. These re-
sults point out the cell type-specific expression of RARs and
RXRs in brain cells. While in TC-620 cells, all RARs and RXR
species were expressed at a high level, in U373-MG cells, the
level of RAR-a, -g and RXRs was considerably lower. In SK-
N-MC cells, all species were expressed, except RAR-g. Surpris-
ingly, in microglial cells, no typical RAR or RXR protein could
be detected.
Functional Effect of Retinoic Acid Receptors on Reporter Gene
Expression in Brain Cells—We first tested the contributions of
RAR and RXR to ligand-dependent transcription from a pro-
moter containing a retinoic acid response element (RARE)
linked to the herpes simplex thymidine kinase promoter and
the CAT gene. The response element consists of two direct
repeat half-sites of the GGGTCA sequence separated by a
5-base pair spacer; it binds efficiently RAR or RXR homodimers
and RAR/RXR heterodimers (21). Each brain cell line was
transfected with the RARE-tk-CAT vector, and CAT activities
were determined. In the absence of transfected receptors, all-
trans-RA elicited a 4–5-fold transcriptional response in glial
cells, confirming the presence of functional endogenous recep-
tors (Fig. 2). 9-cis-RA elicited a 2.4-fold stimulation in TC-620
cells, indicating the presence of functional RXR receptors.
Overexpression of RAR-a or RXR-a increased the transcrip-
tional response to all-trans- or 9-cis-RA, respectively, in all cell
lines, with varying intensities depending on the cell line (Fig.
2). These results are consistent with a number of studies in
FIG. 1. Western blot analysis of nuclear proteins from human
glial, neuronal, and microglial cell lines. Nuclear protein extracts
were prepared from neuronal SK-N-MC (lanes S), oligodendroglioma
TC-620 (lanes T), astrocytoma U373-MG (lanes U), and microglial
(lanes M) cells. Proteins (10 mg) were subjected to an SDS-10% poly-
acrylamide gel, transferred to a nitrocellulose membrane, and probed
with anti-RAR-a, RAR-b, RAR-g, and RXR-a, -b, -g monoclonal anti-
bodies (gift of P. Chambon). The signal was visualized using the en-
hanced chemiluminescence system (Amersham Corp.). The upper band
(NS) in each panel corresponds to a nonspecific immunoreaction. Ar-
rowhead indicates the endogenous retinoic acid receptors. Lower mo-
lecular weight reactive components were found in microglial cells. The
position of the prestained molecular mass markers (Bio-Rad) is indi-
cated in kilodaltons (kDa).
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many other cell types indicating that RAR and RXR behave as
ligand-inducible transcriptional activators (8, 28, 29).
Ligand-independent Activation of LTR-directed Gene Tran-
scription by RAR-a or RXR-a in Brain Cells—To analyze the
regulation of HIV-1 gene expression by RAR, RXR, and retinoic
acid in different brain cells, we performed cotransfection ex-
periments with an expression vector for RAR-a or RXR-a and a
HIV-1 LTR-CAT reporter construct. We used two distinct LTR-
CAT constructs containing the LTR of either the lymphotropic
LAI strain or the neurotropic JR-CSF strain (30). After 24 h,
cells were either treated with 1026 M all-trans- or 9-cis-RA or
left untreated. After further 24 h, cells were harvested and
CAT activities were determined. In TC-620 cells incubated in
the absence of RA, overexpression of RXR-a and RAR-a re-
sulted in a respective 3- and 4-fold transcriptional activation
(Fig. 3). Surprisingly, this stimulation was inhibited by the
presence of RA. Similar effects were observed with both types
LAI and JR-CSF LTR. This RA-mediated inhibition contrasts
with the RA-induced activation observed with the RARE-tk-
CAT vector in the same cells, suggesting that the configuration
of the retinoid response element in the HIV-1 LTR could be
responsible for this effect. In contrast, in U373-MG, SK-N-MC,
and microglial cells, retinoic acid receptors, and RA were un-
able to significantly modify HIV-1 CAT activity (Fig. 3). The
effect of RA concentration on RA-mediated inhibition of LTR
activity was tested in TC-620 cells. Maximal inhibition by RA
was achieved at 1028 M and half-maximal inhibition occurred
at 10210 M (Fig. 4).
Retinoic Acid Receptors Act on the NRRE and on Down-
stream-located Sites of the HIV-1 LTR in TC-620 Cells—Previ-
ous studies performed in non-CNS-derived cells have shown
that RAR and RXR stimulate transcription of the HIV-1 LTR
via the NRRE site (8, 9). Other investigators (16) have shown
that RA inhibits transactivation of the HIV-1 LTR via the
NF-kB element in HeLa cells. To identify the region of the LTR
responsible for the retinoid response in TC-620 cells, we per-
formed transfection experiments using LTR-CAT vectors con-
taining progressive 59 deletions of the LTR LAI and JR-CSF
region (Fig. 5). Deletion of the NRRE site up to position 2283
(constructs 2) reduced the RAR- and RXR-mediated transcrip-
tional activation of LTR LAI by 40% and did not modify the
activation of LTR JR-CSF. Removal of the AP-1 site present in
the LTR JR-CSF (construct 3) resulted in a 60% decrease of
CAT activity. Further deletion of the NF-kB sites up to position
268 (construct 4) abolished the transcriptional stimulation
(Fig. 5). These results point out the difference in the molecular
interactions that control LTR LAI and LTR JR-CSF gene tran-
scription. They indicate that the NRRE site of LTR JR-CSF is
not involved in the RAR-mediated effect; cross-coupling inter-
actions, especially with the AP-1 element, are likely to contrib-
ute for the most part to the retinoid effect. In contrast to LTR
JR-CSF, the NRRE site of LTR LAI is involved to some extent
in the RAR-mediated activation, together with downstream-
located elements, such as NF-kB. However, the precise na-
ture of the complex molecular interactions remains to be
determined.
Regulation of HIV-1 (JR-CSF) LTR-driven Expression by
Transcription Factors Acting on the NRRE Site in Brain
Cells—To examine the effect of heterodimerization of nuclear
receptors on LTR-driven gene transcription, we cotransfected
TC-620 cells with RAR-a and RXR-a vectors in equal amounts.
Surprisingly, the results showed that, in contrast with RAR or
RXR homodimers, RAR/RXR heterodimers possess no ability to
enhance transcription (Fig. 6).
Previous reports have described that RAR or RXR are able to
form heterodimers with the orphan nuclear receptor COUP-TF
(31, 32). We have recently shown that COUP-TF, present in
different brain cells, interacts with the NRRE sequence (10)
and functions as a potent activator of LTR-directed HIV-1 gene
expression in TC-620 cells (Fig. 6).2 COUP-TF has been de-
scribed as a repressor of the retinoid response of the HIV-1 LTR
in CV-1 cells (8). We therefore investigated whether COUP-TF
could antagonize RAR- or RXR-mediated induction from the
neurotropic JR-CSF LTR. Cotransfection experiments per-
formed in TC-620 cells showed that COUP-TF did not repress
the retinoid action; in contrast, the retinoid receptors func-
tioned as repressors of COUP-TF-induced activation and re-
duced transcription to a level similar to that obtained with the
receptors alone (Fig. 6).
Nuclear receptors are known to modulate gene expression by
acting as transrepressors of the transcription factor AP-1
(JUN-JUN, or JUN-FOS) activity (for review, see Ref. 33). We
have reported previously that c-JUN and COUP-TF were able
to stimulate 7- and 10-fold, respectively, the CAT activity of the
LTR(JR-CSF)-CAT vector (Ref. 10; Fig. 6).2 We therefore in-
vestigated by cotransfection experiments whether the com-
bined action of different nuclear receptors and c-JUN was able
to modulate HIV-1 gene transcription. When both COUP-TF
and c-JUN expression vectors were cotransfected together, c-
JUN did not significantly alter COUP-TF-mediated stimula-
tion. Interestingly, overexpression of both RXR and c-JUN
proteins resulted in a drastic decrease of the c-JUN-induced
stimulation. In contrast, RAR was unable to antagonize the
positive c-JUN response (Fig. 6). These results reveal the im-
portance of RXR in repressing the c-JUN-mediated transacti-
vation of the HIV-1 LTR.
To examine whether cross-coupling interactions between nu-
clear receptors and AP-1 occurred on the NRRE site, we first
performed transfection experiments using a reporter vector
containing the NRRE sequence linked to the thymidine kinase
promoter and the CAT gene. Interestingly, this 3L-tk-CAT
reporter vector led to a 4-fold increase in CAT activity in the
presence of the COUP-TF expression vector and to a 5-fold
increase in the presence of a c-JUN expression vector (Fig. 7,
lanes 12 and 13). Overexpression of both c-JUN and COUP-TF
FIG. 2. Effect of all-trans- and 9-cis-RA on transcription from a
promoter containing a DR5 response element. Transient expres-
sion experiments were performed in human oligodendroglioma TC-620,
astrocytoma U373-MG, and neuroblastoma SK-N-MC cells. A reporter
vector containing the DR5G retinoic acid response element linked to the
herpes simplex thymidine kinase (tk) promoter and the CAT gene (21)
was cotransfected with expression vectors for RAR-a or RXR-a as indi-
cated. 24 h after transfection, cells were exposed to 1 mM of either
all-trans-RA or 9-cis-RA as indicated. Cell extracts were prepared 48 h
after transfection, and CAT assays were performed. Results are the
average of at least three independent experiments done in duplicate.
Nuclear Receptors and HIV-1 Gene Expression in Brain 22897
 at U
niv of Queensland (CAUL) on June 21, 2015
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
led to a 7-fold increase in CAT activity (lane 16). As a control,
the activity of the control 3Lmut-tk-CAT vector, containing a
mutant NRRE site unable to bind COUP-TF, remained un-
changed (lanes 17–24). Since we recently demonstrated that
AP-1 is unable to directly bind to the NRRE sequence (10), this
result suggests that AP-1 is able to interact, directly or indi-
rectly, with COUP-TF bound to the NRRE site.
Surprisingly, in TC-620 cells, the NRRE site was unable to
confer RAR or RXR responsiveness on the tk promoter (lanes 10
and 11), in contrast to results reported in F9 cells (7). However,
cotransfection of RAR or RXR and the c-JUN expression vector
strongly decreased the c-JUN-induced stimulation (lanes 14
and 15). Since c-JUN interacts indirectly with the NRRE site,
this result reveals that c-JUN is able to modulate transcription
via the NRRE site by interacting, directly or indirectly, with
COUP-TF, RAR, or RXR.
We recently described that overexpression of c-JUN in-
creased the CAT activity of the 5N-tk-CAT vector, containing
the AP-1 binding site spanning the 2247/2222 region of the
JR-CSF LTR (10). It was interesting to test whether, vice versa,
RXR was able to modulate the positive effect of c-JUN acting on
its DNA binding site. Overexpression of RXR and c-JUN re-
sulted in a 50% decrease of c-JUN-induced stimulation (results
not shown), indicating that cross-coupling interactions between
RXR and c-JUN modulate transcription from the 5N-tk pro-
moter. Taken together, these results suggest that, within the
JR-CSF LTR, RXR and c-JUNmodulate transcription by acting
either on the NRRE or on the AP-1 site.
DISCUSSION
In this report we have investigated the regulation of HIV-1
gene transcription in human brain cells by transcription fac-
tors that interact, directly or indirectly, with the nuclear re-
ceptor response element (NRRE), spanning the 2356/2320
region of the lymphotropic LAI and the neurotropic JR-CSF
LTR.
Regulation of HIV-1 LTR-directed Gene Transcription by
RAR, RXR, and RA—We have first focused our studies on
nuclear receptors belonging to the RAR and RXR families. Our
results show that different members of the RAR and RXR
families are present in human glial and neuronal cells. Sur-
prisingly, no typical member of the retinoid family could be
detected in human microglial cells, which represent the pri-
mary target of HIV-1 infection in brain. Since these results
were obtained in a microglial cell line, it would be interesting to
examine the existence of these receptors using primary cul-
tured microglial cells.
Nuclear receptors are known to mediate both positive and
negative effects on promoter activity in response to ligand
binding (34). A number of reports have described the use of
retinoids to alter HIV-1 replication in certain cell types. Reti-
noic acid exerts various effects on the replication of HIV, which
depend on the type of target cell and the time of treatment
(17–19).
Our transient expression data indicate that in different
brain cells RAR-a and RXR-a are able, in response to ligand
binding, to activate transcription of a thymidine kinase pro-
moter driven by a retinoic acid response element. However,
these receptors are unable, in the presence or absence of their
ligand, to affect HIV-1 LTR-driven gene expression in astrocy-
toma, neuronal, and microglial cells. In contrast, in oligoden-
droglioma TC-620 cells, RAR-a and RXR-a function as activa-
tors of HIV-1 gene transcription in the absence of ligand
binding. Interestingly, in the presence of all-trans- or 9-cis-
retinoic acid, the stimulation mediated by unliganded RAR or
RXR is almost completely reversed. A similar negative effect of
RA on HIV-1 LTR activity was recently described in HeLa cells
and the U937 monocyte cell line (16). In contrast, a RA-depend-
ent stimulation of HIV-1 gene transcription by RAR and RXR
was reported in choriocarcinoma JEG-3 cells and in CV1 cells
(8, 9). These distinct transcriptional effects may be accounted
for by the existence of recently described cell-type specific co-
activators or co-repressors (35, 36).
Several mechanisms of negative regulation by nuclear recep-
tors have been reported (33, 34). One mechanism has been
described for thyroid hormone receptors (T3R); thyroid hor-
mone (T3) inhibits stimulation mediated by unliganded T3R, in
FIG. 3. Ligand-independent activation of HIV-1 LTR by RAR-a and RXR-a. Expression vectors encoding RAR-a or RXR-a (0.5 pmol) or
the parental pSG1 vector were cotransfected into the human brain cell lines with the indicated HIV-1 LTR-CAT reporter constructs (1 pmol). The
LTR LAI extends from position 2489 to 180. The LTR JR-CSF contains the 2421 to 120 region. 24 h after transfection, cells were incubated for
further 24 h in the presence (lanes 1) or the absence (lanes 2) of either all-trans-RA (lanes pSG1 and RAR) or 9-cis-RA (lanes RXR). CAT activities
were determined as described under “Materials and Methods.” Top, histograms show the relative CAT activities calculated from the value of the
pSG1 control set at 1. Right panel, autoradiograms of one typical CAT assay obtained with TC-620 cells.
FIG. 4. Retinoic acid dose response of HIV-1 LTR-CAT activa-
tion by RAR. HIV-1 LTR(JR-CSF)-CAT (1 pmol) and RAR-a expres-
sion vector (0.5 pmol) were cotransfected into TC-620 cells. Cells were
treated with all-trans-RA for 24 h, and CAT activities were determined
as described in Fig. 2. Results represent the average of four experi-
ments done in duplicate.
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the LTR of Rous sarcoma virus and in the LTR of HIV-1. T3R
has been shown to interact with several sites in the HIV-1
proximal promoter spanning the NF-kB and the Sp1 elements
(37), although other investigators found that T3R binds to a
single site overlapping the Sp1 sequence (38). A second mech-
anism involves blocking a positive transcription factor such as
AP-1; it appears that DNA binding by the receptor may not be
sufficient or even required for ligand-dependent repression and
that an interplay with additional factors may be involved.
Our findings reveal that, depending on the LTR sequence,
both mechanisms are likely to be involved in the RAR and RXR
regulation of HIV-1 gene transcription in TC-620 cells. In the
lymphotropic HIV-1 LAI strain, the NRRE site plays a major
role in RAR- and RXR-mediated transcriptional stimulation.
Similarly, the NRRE site was found to be responsible for the
ligand-dependent activation mediated by RAR and RXR in
JEG-3 (9) and in CV1 cells (8). When the NRRE sequence was
deleted, downstream-located elements, such as NF-kB, are
able, to some extent, to mediate the RAR and RXR action in
TC-620 cells. Similarly, the NF-kB element was shown to be
responsible for the negative effect of RA on HIV LTR activity in
HeLa and U937 cells (16). In contrast, the NRRE site in the
LTR of the neurotropic JR-CSF strain is not indispensable for
the retinoid effect, since removal of the NRRE region did not
affect transcription. The retinoid action can be mediated by
downstream-located elements, such as the 2247/2222 AP-1
region, recently described in the LTR JR-CSF (10) and, to a
lesser extent, the NF-kB region. Similarly, distinct mecha-
nisms, depending on the LTR sequence, were found to govern
COUP-TF-induced stimulation in TC-620 cells.2 These data
show how sequence variations in regulatory sites within the
LTR modify the binding properties of transcription factors and
further demonstrate the flexibility of the interactions between
various elements of the LTR.
Regulation of HIV-1 JR-CSF LTR-directed Gene Transcrip-
tion by RAR and RXR in the Presence of COUP-TF or AP-1—
Multiple nuclear receptors bind to the NRRE and modulate
HIV-1 LTR-driven transcription in non-CNS-derived cells (9).
We have previously shown that the orphan nuclear receptor
COUP-TF is expressed at a high level in brain cells and leads
to a dramatic transcriptional stimulation in oligodendroglioma
TC-620 cells.2 In contrast to results described in CV1 cells,
where COUP-TF had no action by itself and repressed the
retinoid response (8), our data reveal that either RAR or RXR
is able to dramatically inhibit the COUP-TF function. More-
over, high levels of RXR expression repress RAR activity, which
suggests that the transcriptional activity of the LTR may be
modulated by the relative amount of RXR present in TC-620
cells. Thus regulation of LTR-driven transcription may depend
on the actual cell concentration of RARs, RXRs, COUP-TF, as
well as of cell-specific transcriptional intermediary factors,
which are responsible for coupling the transcription factors to
the transcription machinery.
In addition, our findings reveal that the nuclear receptor
signaling pathway, by interfering with the AP-1 pathway, is
able to inhibit HIV-1 gene expression. We have described pre-
viously that the transcription factor AP-1, composed of the JUN
FIG. 5. Delineation of RA-responsive elements by deletion analysis of the HIV-1 LAI or JR-CSF LTR. Right panel, plasmid constructs
of the HIV-1 LTRs used in transient expression assays. The LTR LAI (2489/180) and LTR JR-CSF (2421/120) were 59-end-deleted. The Ap-1 site
is not present in LTR LAI. Left panel, fold stimulation in CAT activity obtained with TC-620 cells cotransfected with the LTR-CAT constructs and
the RAR-a expression vector, followed by all-trans-RA treatment 24 h after transfection.
FIG. 6. Regulation of HIV-1 LTR-driven transcription by nu-
clear receptors in TC-620 cells. Transient expression experiments
were performed in TC-620 cells. The reporter vector HIV-1 LTR(JR-
CSF)-CAT (1 pmol) was cotransfected with either the parental pSG1
plasmid or vectors (0.5 pmol) expressing transcription factors as indi-
cated. Cell extracts were prepared 48 h after transfection, and CAT
activities were determined. Values correspond to an average of at least
three independent experiments done in duplicate. The standard devia-
tion did not exceed 20%.
FIG. 7. Transactivation of reporter genes containing the
NRRE site by coexpressed RAR-a, RXR-a, COUP-TF, or c-JUN.
CAT assays were performed with extracts of TC-620 cells that were
cotransfected with the indicated pBL-CAT2 reporter vectors (shown on
bottom) and expression vectors (on the left). Oligonucleotides 3L and
3Lmut correspond to the wild-type and mutant NRRE sequence, respec-
tively. CAT activities are expressed relative to the activity of each
reporter vector set at 1. They correspond to the average of at least three
independent experiments done in duplicate.
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and FOS proteins, stimulates transcription from the LTR(JR-
CSF) promoter in TC-620 cells, by acting on the 2247/2222
binding site (10). Here our data further reveal the existence of
direct or indirect interactions between the c-JUN component of
AP-1 and nuclear receptors bound to the upstream-located
NRRE site. Vice versa, cross-coupling interactions are likely to
occur between RXR and c-JUN acting on the AP-1 site. These
findings may explain the antagonism between RXR and c-JUN,
which leads to a strong inhibition of the c-JUN response. In
contrast RAR is not able to antagonize the positive action of
c-JUN. A number of studies have demonstrated the interplay
between the regulatory circuits stimulated by AP-1 and those
activated by nuclear receptors. Inhibition of AP-1 activity by
RARs was reported in non-CNS-derived cells, and RXRs were
described to inhibit AP-1 binding to its TRE site in vitro. Vice
versa, AP-1 was shown to antagonize the activity of several
hormone receptors through protein-protein interactions (for
review, see Ref. 33). Interestingly, while RAR-mediated AP-1
transrepression has been described to be ligand-dependent, our
findings reveal a ligand-independent effect. The molecular
mechanisms underlying AP-1 transrepression by RAR or RXR
remain elusive; however, the concept has emerged that AP-1
and nuclear receptors do not interact directly but act indirectly
through transcriptional mediators (for review, see Ref. 33).
Our data reveal the complexity of the protein-protein inter-
actions between nuclear receptors and AP-1 as well as the
diversity of their interactions with different LTRs. Since the
AP-1 transcription factor is composed of different members of
the JUN and FOS family, it would be interesting to examine
whether the composition of the AP-1 complex is critical for
RXR-mediated repression and for overall modulation of HIV-1
gene transcription. In conclusion, our data demonstrate the
importance of the retinoid receptor pathway in the inhibition of
HIV-1 gene transcription in TC-620 cells. It is noteworthy that
the positive effect of RAR or RXR is inhibited by the presence of
retinoic acid. Moreover, while RAR contributes to repress the
positive COUP-TF response, RXR, by antagonizing the positive
action of distinct transcription factors, such as RAR, COUP-TF,
and AP-1, is a potent negative regulator of HIV-1 gene
transcription.
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